Oulu University Hospital
Oulu, 90220, Finland
NCT Number: NCT00605202
This clinical trial is designed to study the effect of the combination of licorice and hydrochlorothiazide on plasma potassium levels in volunteers. In one arm, 10 healthy volunteers will be given 32 grams of licorice a day together with a 25 mg dose of daily hydrochlorothiazide for 14 days. This combination is compared with 32 grams of licorice a day for 14 days given in the other arm. The study is a randomized, open-label cross-over trial. There is at least a 3-week wash-out between the arms. The hypothesis is that the combination of licorice and hydrochlorothiazide will cause hypokalemia. The main outcome measure is the change in the plasma level of potassium between the arms.
Looking for future studies?
Notify Me18 year–40 year
All sexes
Interventional
Phase 4
Oulu, 90220, Finland
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Hydrochlorothiazide 25 mg a day for 14 days.
Other names: Hydrex semi, ATC C03AA03
Licorice candy 32 grams a day for 14 days.
Other names: Pepe Original candy
Time frame: Baseline and 2 weeks
Plasma potassium measured with indirect ion specific electrode method
University of Oulu
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05118022
Hyperkalemia, Hypokalemia
Taipei, Taiwan
View Trial DetailsNCT01431326
Adenoviridae Infections, Adenovirus
Anchorage, Alaska, United States
View Trial DetailsNCT05184998
Cardiovascular Diseases, Heart Diseases
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT04426994
Arrhythmias, Cardiac, Calcium Metabolism Disorders
Singapore
View Trial Details